BlackRock Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.61M | Sell |
123,064
-561
| -0.5% | -$7.35K | ﹤0.01% | 2369 |
|
|
2016
Q3 | $2.13M | Buy |
123,625
+391
| +0.3% | +$6.74K | ﹤0.01% | 2105 |
|
|
2016
Q2 | $2.22M | Buy |
123,234
+18,604
| +18% | +$336K | ﹤0.01% | 2015 |
|
|
2016
Q1 | $1.99M | Buy |
104,630
+1,935
| +2% | +$36.7K | ﹤0.01% | 2013 |
|
|
2015
Q4 | $2.74M | Buy |
102,695
+368
| +0.4% | +$9.83K | ﹤0.01% | 1848 |
|
|
2015
Q3 | $2.5M | Buy |
102,327
+14,920
| +17% | +$364K | ﹤0.01% | 1906 |
|
|
2015
Q2 | $2.72M | Buy |
87,407
+20,581
| +31% | +$641K | ﹤0.01% | 1991 |
|
|
2015
Q1 | $972K | Buy |
66,826
+488
| +0.7% | +$7.1K | ﹤0.01% | 2534 |
|
|
2014
Q4 | $667K | Buy |
66,338
+400
| +0.6% | +$4.02K | ﹤0.01% | 2822 |
|
|
2014
Q3 | $549K | Buy |
65,938
+11,293
| +21% | +$94K | ﹤0.01% | 2906 |
|
|
2014
Q2 | $673K | Buy |
+54,645
| New | +$673K | ﹤0.01% | 2856 |
|